3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
13
Unknown
4
Terminated
3
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Nasopharyngeal Carcinoma
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Anus Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
SCLC, Extensive Stage
1
SCLC
1
Retinoblastoma
1
Retinal Neoplasms
1
Recurrence
1
Radiation Therapy
1
Prostatic Neoplasms
1
Interventions
Temozolomide
41
Radiotherapy
19
Radiation
12
Nivolumab
10
pembrolizumab
8
Magnetic Resonance Spectroscopy
8
Bevacizumab
7
Specimen Handling
6
poly ICLC
4
atezolizumab
4
Lomustine
4
Ipilimumab
4
Surgical Procedures, Operative
3
Photons
3
Immunoglobulin G
3
Disulfides
3
Cyclophosphamide
3
veliparib
2
sargramostim
2
rocakinogene sifuplasmid
2
olaparib
2
niraparib
2
Transurethral Resection of Bladder
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
OKN 007
2
Mycophenolic Acid
2
Metformin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Glioblastoma
×
Drug Therapy
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled